| Literature DB >> 34934546 |
Artsiom Klimko1, Alienor Brandt2, Catalin Cirstoiu3,2, Georgian Iacobescu3,2.
Abstract
Transient osteoporosis of the hip (TOH) refers to a temporary, focal reduction in bone mineral density that selectively affects bones in weight-bearing joints of young pregnant females. Due to inherent difficulties in diagnosing this pathology, it is difficult to estimate the incidence and it is conceivable that TOH is vastly underreported. In a rare subset of patients, TOH may progress to pathological fractures. We report a case of a 38-year-old pregnant woman who developed an atraumatic, displaced femoral neck fracture during her last trimester. Diagnosis and adequate management of TOH represents a clinical challenge as symptoms that precede the fracture are often non-specific, while the timing of the surgical treatment (i.e. before or after delivery) is debatable.Entities:
Keywords: atraumatic hip fracture; peripartum; pregnancy; regional osteoporosis; trasient osteoporosis of the hip
Year: 2021 PMID: 34934546 PMCID: PMC8668042 DOI: 10.7759/cureus.19524
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Hip radiography showing a right-sided displaced femoral neck fracture (A, red arrow) and normal lucency of the left hip (B, red arrow).
Figure 2Installation of the total uncemented prosthesis intraoperatively (A, black arrow) and postoperative radiography confirming prosthesis placement (B, red arrow).
Figure 3Summary of proposed pathogenesis of transient osteoporosis of the hip.
Summary of cases describing atraumatic unilateral fracture of the femoral neck due to transient osteoporosis of the hip.
P-P: postpartum; TOH: transient osteoporosis of the hip; C-section: cesarean section; THA: total hip arthroplasty; ORIF: open reduction with internal fixation
| Author and year | Patient age (years) | Gestation week of first symptoms and of the fracture | Gestation week of delivery and method | Suspected initial diagnosis | Type of fracture and side | Diagnosis confirmed with MRI | Treatment | Presumed underlying cause of TOH |
| Our case | 38 | 35, 35 | 35, C-section | Hip fracture | Femoral neck, right side, displaced (grade IV) | No | THA | Idiopathic |
| Tayne et al., 2019 [ | 32 | 31, 38 | 38 weeks, C-section | Compressive femoral nerve neuropathy | Femoral neck, right side, displaced (grade IV) | Yes | THA | Hypoalbuminemia (1.6 g/dL) attributed to malnutrition |
| Kasahara et al., 2018 [ | 40 | 29, 3 days P-P | 36, C-section | Excessive weight-bearing load | Subchondral, left side, collapsed femoral head | Yes | THA | Anorexia nervosa (BMI 15.4 kg/m2) |
| Guryel et al., 2010 [ | 31 | 38, 38 | 38, C-section | Hip fracture | Subcapital, left side, displaced (grade IV) | No | ORIF | Generalized osteopenia |
| Spinarelli et al., 2009 [ | 35 | Last trimester, 2 weeks P-P | 39, spontaneous vaginal | Low back pain syndrome associated with sciatica | Femoral neck, right side, partially displaced (grade III) | Yes | THA | Idiopathic |
| Cohen et al., 2007 [ | 37 | 19, 29 | 38, spontaneous vaginal | Hip fracture | Femoral neck, left side, partially displaced (grade III) | Yes | ORIF | Idiopathic |
| Wood et al., 2003 [ | 29 | Last trimester, 5 months P-P | 39, spontaneous vaginal | Hip fracture | Subcapital, right side, displaced (grade IV) | No | ORIF with muscle-pedicle bone graft | Idiopathic |
| Henry et al., 2003 [ | 24 | 38, 38 | 42, C-section | Sciatica | Femoral neck, right side, displaced (grade IV) | No | ORIF | Osteomalacia due to malabsorption syndrome |
| Fokter et al., 1997 [ | 20 | 23, 31 | 31, C-section | Sciatica | Subcapital, left side, partially displaced (grade III) | No | ORIF | Idiopathic |
| Junk et al., 1996 [ | 35 | 29, 2 weeks P-P | 39, spontaneous vaginal | Excessive weight-bearing load | Subcapital, left side, displaced (grade IV) | No | ORIF with screws and plate | Idiopathic |
| Fingeroth et al. 1995 [ | 27 | 35, 35 | 39, spontaneous vaginal | Excessive weight-bearing load | Subcapital, right side, displaced (grade IV) | No | ORIF | Grand mal seizure |
Lab values upon admission.
MCV: mean corpuscular volume; PT: prothrombin time; INR: international normalized ratio; aPTT: activate partial thromboplastin time
| Lab value | Reference range | Lab value at admission |
| Complete blood count | ||
| Hemoglobin (g/dL) | 13-17.5 | 9.3 |
| RBCs (x 10^6/uL) | 3.6-4.9 | 2.97 |
| WBCs (x 10^3/uL) | 4-10 | 13.9 |
| Hematocrit (%) | 31-41 | 27.1 |
| MCV (fL) | 75-95 | 91.2 |
| Platelets (x 10^3/uL) | 179-408 | 225 |
| Biochemistry | ||
| Fibrinogen (mg/dL) | 238-498 | 558 |
| Blood glucose (mg/dL) | 74-106 | 65 |
| Creatinine (mg/dL) | 0.51-0.95 | 0.35 |
| Creatinine kinase-myocardial band (U/L) | 0-24 | 18 |
| Alanine aminotransferase (U/L) | 5-35 | 31 |
| Aspartate aminotransferase (U/L) | 5-35 | 21 |
| Coagulation Studies | ||
| PT (seconds) | 9.4-12.5 | 10.8 |
| INR | 0.8-1.1 | 0.98 |
| PT (%) | 80-130 | 102 |
| aPTT (seconds) | 22.0-36.0 | 32.0 |